Shopping Cart
Remove All
Your shopping cart is currently empty
Avotaciclib (Synonyms: BEY1107, Avotaciclib)
Catalog No. T39403 Copy Product Info
Purity: 98.02%
🥰Excellent
Avotaciclib (BEY1107) is a potent, orally active cyclin-dependent kinase 1 (CDK1) inhibitor, suitable for research in locally advanced or metastatic pancreatic cancer.
Avotaciclib
Copy Product Info🥰Excellent
Catalog No. T39403
Synonyms BEY1107, Avotaciclib
Avotaciclib (BEY1107) is a potent, orally active cyclin-dependent kinase 1 (CDK1) inhibitor, suitable for research in locally advanced or metastatic pancreatic cancer.
Cas No. 1983983-41-0
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $119 | In Stock | In Stock | |
| 5 mg | $287 | In Stock | In Stock | |
| 10 mg | $456 | In Stock | In Stock | |
| 25 mg | $749 | In Stock | In Stock | |
| 50 mg | $1,060 | In Stock | In Stock | |
| 100 mg | $1,420 | - | In Stock | |
| 500 mg | $2,850 | - | In Stock |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
Custom-made molecule. TargetMol’s expert synthesis team delivers cost-effective solutions. Contact us for inquiries. Committed to serving you.
For research use only—not for human use. No sales to individuals. Use as intended only.
Batch Information
Select Batch
Purity:98.02%
Appearance:Solid
Color:Yellow
Contact us for more batch information
Product Introduction
Avotaciclib AI Summary
Avotaciclib shows potent inhibitory activity against CDK1/Cyclin B, CDK2/Cyclin E, and CDK5/p35 with IC50 values of 1.5 nM, 1.5 nM, and 2.4 nM, respectively. However, its inhibitory effect on CDK6/Cyclin D is weaker with an IC50 value greater than 200 nM. Additionally, its inhibitory activity against CDK4/Cyclin D is moderate, with an IC50 value of 854.5 nM..
Note: Summary generated by AI. Data source: ChEMBL 
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | Avotaciclib (BEY1107) is a potent, orally active cyclin-dependent kinase 1 (CDK1) inhibitor, suitable for research in locally advanced or metastatic pancreatic cancer. |
| Synonyms | BEY1107, Avotaciclib |
| Molecular Weight | 281.27 |
| Formula | C13H11N7O |
| Cas No. | 1983983-41-0 |
| Smiles | OC1=C(N=C(C=C1)C2=NC(N)=NC=C2)C3=NC(N)=NC=C3 |
| Relative Density. | 1.487 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (177.77 mM), Sonication is recommended.  | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 
10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.Stock Solution Preparation:
Dissolve 2 mg of the compound in 100 μL DMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
Preparation of the In Vivo Formulation:
1) Add 100 μL of the DMSO stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O and mix thoroughly until a homogeneous solution is obtained.
This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Avotaciclib | purchase Avotaciclib | Avotaciclib cost | order Avotaciclib | Avotaciclib chemical structure | Avotaciclib formula | Avotaciclib molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.